Hem › KOL › Kalifornien › San Diego
Kliniska studier för KOL i San Diego, CA
4 studier för KOL söker deltagare vid platser i och runt San Diego (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
RekryterarFas 3
- Acclaim Clinical Research- Site Number : 8400068, San Diego
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
RekryterarFas 2
- Institute of HealthCare Assessment d/b/a Apex Clinical Research, San Diego
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
RekryterarFas 2/3
- Institute of HealthCare Assessment d/b/a Apex Clinical Research, San Diego
The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
RekryterarFas 2
- UCSD Sleep Research, La Jolla · 11 mi bort
KOL-studier i andra städer
- Philadelphia, PA23 studier
- Miami, FL18 studier
- Birmingham, AL17 studier
- Boston, MA17 studier
- Houston, TX15 studier
- Orlando, FL15 studier
- Baltimore, MD14 studier
- Chicago, IL14 studier
- Dallas, TX12 studier
- Pittsburgh, PA12 studier
- New York City, NY11 studier
- Ann Arbor, MI10 studier
Andra studier i San Diego
- Icke-småcellig lungcancer48 studier
- Bröstcancer41 studier
- Cancer (alla typer)32 studier
- Prostatacancer31 studier
- Metastaserande cancer30 studier
- Kolorektal cancer25 studier
- Bukspottkörtelcancer24 studier
- Äggstockscancer24 studier
- Lungcancer23 studier
- Hjärtsvikt23 studier
- Övervikt23 studier
- Depression21 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.